- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.03. | Takeda rains 100 toy zebras down on Boston Celtics fans to mark Rare Disease Day | ||
| 03.03. | Roche touts head-to-head data for Xolair against oral immunotherapy for treating food allergies | ||
| 03.03. | Sinusitis data from Amgen, AstraZeneca's Tezspire spark 'best-in-disease' talk amid Sanofi, GSK competition | ||
| 03.03. | Bristol Myers' cost savings drive claims another 223 jobs in NJ | ||
| 28.02. | Apellis warns of Q1 growth speed bump, touts TV advertising push to grow Syfovre | ||
| 28.02. | Lilly promotes 'healthy skepticism' toward compounded drugs in new Oscars ad campaign | ||
| 28.02. | Eisai, Biogen's Leqembi emerges from safety reappraisal unscathed as Europe's CHMP endorses slate of new drugs and label expansions | ||
| 28.02. | Arrowhead, Zevra fire up campaigns for Rare Disease Day 2025 | ||
| 28.02. | If GSK thrives in '25, CEO Emma Walmsley's pay could more than double to $27M | ||
| 27.02. | Merck nabs $30M grant commitment from Delaware as state looks to entice Big Pharma investment | ||
| 27.02. | Eisai to part ways with 121 employees amid new US restructuring effort | ||
| 27.02. | Launch metrics of Madrigal's MASH drug Rezdiffra track 'exceptionally well,' CEO says | ||
| 27.02. | BeiGene fleshes out global ambition as Brukinsa surpasses AstraZeneca's Calquence in quarterly sales | ||
| 27.02. | Zevra to net $150M from priority review voucher sale tied to Miplyffa approval | ||
| 27.02. | FDA committee meeting scrapped, reports say, in 2nd vaccine-related scheduling disruption in as many weeks | ||
| 26.02. | Endo highlights a Xiaflex success story in first branded commercial for Dupuytren's contracture treatment | ||
| 26.02. | Schwarzenegger spins 'Terminator' catchphrase for Zimmer Biomet's big marketing push | ||
| 26.02. | Merck expects oncology king Keytruda to face IRA 'price setting' process starting in 2026 | ||
| 26.02. | Jazz 'active and looking' at M&A deals of 'various sizes' as it wraps up Epidiolex patent fights: execs | ||
| 26.02. | FDA dings Piramal API plant with Form 483 detailing problems tied to quality control, equipment cleaning and more | ||
| 26.02. | With $27B plan to build 4 new plants, Eli Lilly doubles down on US drug manufacturing | ||
| 25.02. | Eli Lilly makes Zepbound vials cheaper for self-paying patients | ||
| 25.02. | Compounders sue FDA again over declaring end of shortage for Novo's semaglutide | ||
| 25.02. | Grail goes 'Grey's': Actor Kate Walsh joins awareness campaign for multi-cancer early detection testing | ||
| 25.02. | In $4.1B deal, Thermo Fisher buys 3M spinoff's filtration unit to beef up bioproduction |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
